Notably, both RNA-seq and RT-qPCR analyses consistently demonstrated significant downregulation of CDK1 mRNA expression following PAB treatment (Figure 4D), which strongly suggests that CDK1 plays a crucial role in mediating PAB’s anti-tumor effects. The gene discussed is CDK1; the disease is neoplasm.